Depression Before and After a Diagnosis of Pancreatic Cancer Results From a National, Population-Based Study
Depression Before and After a Diagnosis of Pancreatic Cancer Results From a National, Population-Based Study
复制标题
DOI:
10.1097/mpa.0000000000001635
复制
发表时间:
2020-09-01
期刊:
影响因子:
2.9
通讯作者:
Thakkar, Shyam
中科院分区:
文献类型:
--
作者:
Seoud, Talal;Syed, Aslam;Thakkar, Shyam
Objectives The aim of this study was to evaluate depression in pancreatic cancer (PC) patients before and after a cancer diagnosis using a US-based healthcare database. We also sought to study the impact of treatment of depression in PC patients on all-cause mortality. Methods Pancreatic cancer patients with comorbid depression in Explorys (1999-2019) were compared with controls using odds ratios with 95% confidence intervals. Rates of depression diagnosed within 6 months, 1 year, and 3 years before and after a PC diagnosis were recorded. Patients who developed depression after a PC diagnosis were further categorized into those treated for depression using mental health professionals (MHPs), pharmacologic treatment, or both (2015-2019). Results Of the 62,450 PC patients, 10,220 (16.4%) were diagnosed with depression before PC and 8130 (13%) were diagnosed with depression after PC. Patients diagnosed with depression after PC had a significantly higher all-cause mortality than patients with PC alone (P< 0.0001). Involvement of MHP significantly improved all-cause mortality (P= 0.0041). Conclusions Most post-PC depression is diagnosed in the first 6 months after a PC diagnosis. Although depression significantly increases PC mortality, integrating MHP in the care of PC patients with depression improves outcomes.